Renal safety and biochemical changes for 2?years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B-论文-万方医学网

首页> > Renal safety and biochemical changes for 2?years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B

Renal safety and biochemical changes for 2?years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B

导出原文传递

翻译打印收藏纠错

第一作者： Tetsuya Hosaka

作者： Tetsuya Hosaka ^[1] ; Fumitaka Suzuki ^[2] ; Masahiro Kobayashi ; Shunichirou Fujiyama ; Yusuke Kawamura ; Hitomi Sezaki ; Norio Akuta ; Yoshiyuki Suzuki ; Satoshi Saitoh ; Yasuji Arase ; Kenji Ikeda ; Mariko Kobayashi ; Hiromitsu Kumada

作者单位： Department of Hepatology,Toranomon Hospital ^[1] Research Institute for Hepatology ^[2]

关键词 adefovir dipivoxil alanine aminotransferase estimated glomerular filtration rate tenofovir alafenamide tenofovir disoproxil fumarate

发布时间 2022-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Renal safety and biochemical changes for 2?years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B

相似文献

同项目论文

相关期刊

检索历史 清除

Renal safety and biochemical changes for 2?years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B

相似文献

同项目论文

相关期刊

检索历史清除